JPRN-jRCT2080222924未知3 期
ong-term study of HP-3060 in patients with perennial allergic rhinitis
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with a diagnosis of perennial allergic rhinitis and symptoms of this condition for at least two years.
排除标准
- •- Patients with rhinosinusitis or with types of rhinitis other than allergic rhinitis, including vasomotor rhinitis and non-allergic rhinitis with eosinophilia.
- •- Patients receiving hyposensitization therapy or nonspecific immunotherapy who have not reached the maintenance stage.
研究者
相似试验
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
3 期
ong-term phase III study in patients with chronic pain.Chronic painJPRN-jRCT2080221311Hisamitsu Pharmaceutical Co., Inc.
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
已完成
3 期
A long-term extension study of HP-5070 in patients with primary hyperhidrosisPrimary local hyperhidrosisJPRN-jRCT2031200143Customer Service Office120